Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 4
1991 3
1992 1
1993 1
1994 2
1999 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors.
Sparano JA, Fisher RI, Weiss GR, Margolin K, Aronson FR, Hawkins MJ, Atkins MB, Dutcher JP, Gaynor ER, Boldt DH, et al. Sparano JA, et al. J Immunother Emphasis Tumor Immunol. 1994 Oct;16(3):216-23. doi: 10.1097/00002371-199410000-00006. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7834121 Clinical Trial.
13 results